STING1 and cancer: Considering the pro-tumor effects of AGK in tumor cells and its ability to suppress the mtDNA-induced cGAS-STING pathway in macrophages, targeting AGK may offer a novel and promising strategy for enhancing immunotherapy in the context of cancer treatments.